News
01.06.2026
SafeAlleleSCA Wins the Jorge Ruas Award at the Tecnimede Open Innovation Competition 2026
SafeAlleleSCA, a pioneering precision gene therapy project for Machado–Joseph disease, has been awarded the €100,000 Jorge Ruas Award at the Final Event of the Tecnimede Open Innovation Competition
16.07.2025
Meet the 10 Finalists Competing for the Jorge Ruas Award
18.12.2025
Applying to the Tecnimede Open Innovation Competition 2026? Join one of our four online info sessions taking place on 8 January, 28 January, 19 February or 4 March at 11:00 GMT.
12.12.2025
Applications are open for the Tecnimede Open Innovation Competition! Win the €100k Jorge Ruas Award and unlock potential collaboration opportunities with Tecnimede Group to shape the future of pharmaceutical technologies.
11.05.2026
Final Event to showcase breakthrough pharmaceutical technologies in Lisbon
The Tecnimede Open Innovation Competition is entering its final stage, bringing together international experts, researchers, startups, investors, and pharmaceutical innovation stakeholders for the 2026 Final Event. The Final Event will take place on 27 May, from 14:00 to 18:10, at
03.03.2025
5 Days Left to apply to the Tecnimede Open Innovation Competition: €100K + Tecnimede Partnership Awaits Your pharmaceutical technology innovation!
17.01.2025